Literature DB >> 23950152

Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa.

Lori S Sullivan1, Sara J Bowne, Melissa J Reeves, Delphine Blain, Kerry Goetz, Vida Ndifor, Sally Vitez, Xinjing Wang, Santa J Tumminia, Stephen P Daiger.   

Abstract

PURPOSE: To screen samples from patients with presumed autosomal dominant retinitis pigmentosa (adRP) for mutations in 12 disease genes as a contribution to the research and treatment goals of the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE).
METHODS: DNA samples were obtained from eyeGENE. A total of 170 probands with an intake diagnosis of adRP were tested through enrollment in eyeGENE. The 10 most common genes causing adRP (IMPDH1, KLHL7, NR2E3, PRPF3/RP18, PRPF31/RP11, PRPF8/RP13, PRPH2/RDS, RHO, RP1, and TOPORS) were chosen for PCR-based dideoxy sequencing, along with the two X-linked RP genes, RPGR and RP2. RHO, PRPH2, PRPF31, RPGR, and RP2 were completely sequenced, while only mutation hotspots in the other genes were analyzed.
RESULTS: Disease-causing mutations were identified in 52% of the probands. The frequencies of disease-causing mutations in the 12 genes were consistent with previous studies.
CONCLUSIONS: The Laboratory for Molecular Diagnosis of Inherited Eye Disease at the University of Texas in Houston has thus far received DNA samples from 170 families with a diagnosis of adRP from the eyeGENE Network. Disease-causing mutations in autosomal genes were identified in 48% (81/170) of these families while mutations in X-linked genes accounted for an additional 4% (7/170). Of the 55 distinct mutations detected, 19 (33%) have not been previously reported. All diagnostic results were returned by eyeGENE to participating patients via their referring clinician. These genotyped samples along with their corresponding phenotypic information are also available to researchers who may request access to them for further study of these ophthalmic disorders. (ClinicalTrials.gov number, NCT00378742.).

Entities:  

Keywords:  DNA sequencing; eyeGENE; inherited retinal diseases; mutation prevalences; retinitis pigmentosa

Mesh:

Substances:

Year:  2013        PMID: 23950152      PMCID: PMC3778873          DOI: 10.1167/iovs.13-12605

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

Review 1.  Genetic ophthalmology and the era of clinical care.

Authors:  Paul A Sieving; Francis S Collins
Journal:  JAMA       Date:  2007-02-21       Impact factor: 56.272

2.  Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.

Authors:  Lori S Sullivan; Sara J Bowne; David G Birch; Dianna Hughbanks-Wheaton; John R Heckenlively; Richard Alan Lewis; Charles A Garcia; Richard S Ruiz; Susan H Blanton; Hope Northrup; Anisa I Gire; Robyn Seaman; Hatice Duzkale; Catherine J Spellicy; Jingya Zhu; Suma P Shankar; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

3.  Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa.

Authors:  S Fuchs; H Kranich; M J Denton; E Zrenner; S S Bhattacharya; P Humphries; A Gal
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

4.  Mutations in a novel retina-specific gene cause autosomal dominant retinitis pigmentosa.

Authors:  L S Sullivan; J R Heckenlively; S J Bowne; J Zuo; W A Hide; A Gal; M Denton; C F Inglehearn; S H Blanton; S P Daiger
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

5.  Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause dominant retinitis pigmentosa.

Authors:  E A Pierce; T Quinn; T Meehan; T L McGee; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

6.  Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencing.

Authors:  Sara J Bowne; Lori S Sullivan; Daniel C Koboldt; Li Ding; Robert Fulton; Rachel M Abbott; Erica J Sodergren; David G Birch; Dianna H Wheaton; John R Heckenlively; Qin Liu; Eric A Pierce; George M Weinstock; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-25       Impact factor: 4.799

7.  Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis.

Authors:  Sara J Bowne; Lori S Sullivan; Sarah E Mortimer; Lizbeth Hedstrom; Jingya Zhu; Catherine J Spellicy; Anisa I Gire; Dianna Hughbanks-Wheaton; David G Birch; Richard A Lewis; John R Heckenlively; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

8.  Mutations in the RP1 gene causing autosomal dominant retinitis pigmentosa.

Authors:  S J Bowne; S P Daiger; M M Hims; M M Sohocki; K A Malone; A B McKie; J R Heckenlively; D G Birch; C F Inglehearn; S S Bhattacharya; A Bird; L S Sullivan
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

9.  Clinical features of a previously undescribed codon 216 (proline to serine) mutation in the peripherin/retinal degeneration slow gene in autosomal dominant retinitis pigmentosa.

Authors:  G A Fishman; E Stone; L D Gilbert; K Vandenburgh; V C Sheffield; J R Heckenlively
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079

10.  Molecular genetics of autosomal dominant retinitis pigmentosa (ADRP): a comprehensive study of 43 Italian families.

Authors:  C Ziviello; F Simonelli; F Testa; M Anastasi; S B Marzoli; B Falsini; D Ghiglione; C Macaluso; M P Manitto; C Garrè; A Ciccodicola; E Rinaldi; S Banfi
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

View more
  35 in total

1.  A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.

Authors:  Zhijian Wu; Suja Hiriyanna; Haohua Qian; Suddhasil Mookherjee; Maria M Campos; Chun Gao; Robert Fariss; Paul A Sieving; Tiansen Li; Peter Colosi; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

2.  Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa.

Authors:  Kentaro Kurata; Katsuhiro Hosono; Yoshihiro Hotta
Journal:  Jpn J Ophthalmol       Date:  2018-01-05       Impact factor: 2.447

3.  Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.

Authors:  Simone Iwabe; Gui-Shuang Ying; Gustavo D Aguirre; William A Beltran
Journal:  Exp Eye Res       Date:  2016-04-13       Impact factor: 3.467

4.  Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions.

Authors:  Anna Plana-Bonamaisó; Santiago López-Begines; David Fernández-Justel; Alexandra Junza; Ariadna Soler-Tapia; Jordi Andilla; Pablo Loza-Alvarez; Jose Luis Rosa; Esther Miralles; Isidre Casals; Oscar Yanes; Pedro de la Villa; Ruben M Buey; Ana Méndez
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

5.  A Report on Molecular Diagnostic Testing for Inherited Retinal Dystrophies by Targeted Genetic Analyses.

Authors:  Hema L Ramkumar; Harini V Gudiseva; Kameron T Kishaba; John J Suk; Rohan Verma; Keerti Tadimeti; John A Thorson; Radha Ayyagari
Journal:  Genet Test Mol Biomarkers       Date:  2016-12-22

6.  Mutations in pre-mRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium.

Authors:  Michael H Farkas; Deborah S Lew; Maria E Sousa; Kinga Bujakowska; Jonathan Chatagnon; Shomi S Bhattacharya; Eric A Pierce; Emeline F Nandrot
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

7.  Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa.

Authors:  Ruanne Y J Vent-Schmidt; Runxia H Wen; Zusheng Zong; Colette N Chiu; Beatrice M Tam; Christopher G May; Orson L Moritz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

8.  Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.

Authors:  Artur V Cideciyan; Raghavi Sudharsan; Valérie L Dufour; Michael T Massengill; Simone Iwabe; Malgorzata Swider; Brianna Lisi; Alexander Sumaroka; Luis Felipe Marinho; Tatyana Appelbaum; Brian Rossmiller; William W Hauswirth; Samuel G Jacobson; Alfred S Lewin; Gustavo D Aguirre; William A Beltran
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

9.  Molecular Findings in Families with an Initial Diagnose of Autosomal Dominant Retinitis Pigmentosa (adRP).

Authors:  Stephen P Daiger; Sara J Bowne; Lori S Sullivan; Kari Branham; Dianna K Wheaton; Kaylie D Jones; Cheryl E Avery; Elizabeth D Cadena; John R Heckenlively; David G Birch
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

10.  Ciliopathy-associated protein CEP290 modifies the severity of retinal degeneration due to loss of RPGR.

Authors:  Kollu N Rao; Wei Zhang; Linjing Li; Cecinio Ronquillo; Wolfgang Baehr; Hemant Khanna
Journal:  Hum Mol Genet       Date:  2016-03-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.